A Health Technology Assessment of a Proposed Biosimilar for the Treatment of Chemotherapy Induced Febrile Neutropenia- A United States Payer Perspective
May 1, 2014, 00:00
10.1016/j.jval.2014.03.512
https://www.valueinhealthjournal.com/article/S1098-3015(14)00563-4/fulltext
Title :
A Health Technology Assessment of a Proposed Biosimilar for the Treatment of Chemotherapy Induced Febrile Neutropenia- A United States Payer Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00563-4&doi=10.1016/j.jval.2014.03.512
First page :
A88
Section Title :
Cancer
Open access? :
No
Section Order :
1563